If you are:
FDB Only When Necessary: NO FDA CATEGORY; NEONATE COMPLICATIONS(RESP,GI,CNS) W/EXPOSURE IN 3RD TRIMESTER
Precaution: LOW AMNT EXCR W/SIMILAR DRUG CHLORPROMAZINE, RESULTING IN INFANT DROWSINESS
An adult over 60:
management or monitoring precaution: Neuro/Psych-Higher risk of tardive dyskinesia in the elderly. Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Increased risk of death in senile dementia. Maximum of 8mg/day. Cardiovascular-May cause orthostatic hypotension at higher doses. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
Giving perphenazine to a child under 12:
Severe Precaution: Not recommended for pediatrics under 12 years of age.